Sara M. Tolaney

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al. · New England Journal of Medicine · 2021 · 1.4K citations · Full text

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

Alessandra Gennari, Fabrice André, Carlos H. Barrios et al. · Annals of Oncology · 2021 · 1.3K citations · Full text

Surgical Oncology, Metastatic Breast Cancer, Breast Oncology +8

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

Viktor A. Adalsteinsson, Gavin Ha, Samuel S. Freeman et al. · Nature Communications · 2017 · 1K citations · Full text

Metastatic Tumors, Pathology, Tumor Biology +23

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

William M. Sikov, Donald A. Berry, Charles M. Perou et al. · Journal of Clinical Oncology · 2014 · 1K citations · Full text

BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer

Mingzhao Xing, William H. Westra, Ralph P. Tufano et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 986 citations · Full text